<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>remdesivir &#8211; UF Innovate</title>
	<atom:link href="https://innovate.research.ufl.edu/tag/remdesivir/feed/" rel="self" type="application/rss+xml" />
	<link>https://innovate.research.ufl.edu</link>
	<description>Building business on innovation</description>
	<lastBuildDate>Tue, 12 Aug 2025 04:16:35 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png</url>
	<title>remdesivir &#8211; UF Innovate</title>
	<link>https://innovate.research.ufl.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Two-Drug Combo Shows Dramatic Results for COVID-19 Patients, UF Health Researchers Find</title>
		<link>https://innovate.research.ufl.edu/baricitinib-remdesivir-covid-19/</link>
		
		<dc:creator><![CDATA[Sara Dagen]]></dc:creator>
		<pubDate>Wed, 27 Jan 2021 00:00:00 +0000</pubDate>
				<category><![CDATA[News Brief]]></category>
		<category><![CDATA[UF COVID-19]]></category>
		<category><![CDATA[UF Inventors]]></category>
		<category><![CDATA[baricitinib]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[COVID19]]></category>
		<category><![CDATA[Marie-Carmelle Elie]]></category>
		<category><![CDATA[Nicole Iovine]]></category>
		<category><![CDATA[remdesivir]]></category>
		<guid isPermaLink="false">https://scaddev1.com/baricitinib-remdesivir-covid-19/</guid>

					<description><![CDATA[Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study co-authored by UF Health researchers has found.]]></description>
										<content:encoded><![CDATA[
<p>Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study co-authored by UF Health researchers has found.</p>



<p>Patients treated with a combination of the anti-inflammatory drug baricitinib and the antiviral drug remdesivir while they were receiving high-flow oxygen or noninvasive ventilation had a recovery time of 10 days, compared with 18 days for patients in a remdesivir-only control group.</p>



Read more about <a href="https://ufhealth.org/news/2021/two-drug-combo-shows-dramatic-results-covid-19-patients-uf-health-researchers-find">Two-Drug Combo Shows Dramatic Results for COVID-19 Patients, UF Health Researchers Find.</a>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
